메뉴 건너뛰기




Volumn 94, Issue 3, 2013, Pages 309-311

Legal foundations of adaptive licensing

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

EID: 84883167013     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.95     Document Type: Conference Paper
Times cited : (12)

References (4)
  • 1
    • 84862777400 scopus 로고    scopus 로고
    • Adaptive licensing: Taking the next step in the evolution of drug approval
    • Eichler, H-G. et al. Adaptive licensing: taking the next step in the evolution of drug approval. Clin. Pharmacol. Ther. 91, 426-437 (2012).
    • (2012) Clin. Pharmacol. Ther , vol.91 , pp. 426-437
    • Eichler, H.-G.1
  • 2
    • 84883136083 scopus 로고    scopus 로고
    • US Food and Drug Administration Fast track products 28 June 2012
    • US Food and Drug Administration. Federal Food Drug and Cosmetic Act, Section 356. Fast track products, (28 June 2012).
    • Federal Food Drug Cosmetic Act, Section 356
  • 3
    • 84883177310 scopus 로고    scopus 로고
    • European Commission Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products 15 December 2010; effective 2 July 2012
    • European Commission. Regulation No 1235/2010 of the European Parliament and of the Council: amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products, http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do? uri=OJ:L:2010:348:0001:0016:EN:PDF (15 December 2010; effective 2 July 2012).
    • Regulation No 1235/2010 of the European Parliament and of the Council: Amending, As Regards Pharmacovigilance of Medicinal Products for Human Use
  • 4
    • 34347252630 scopus 로고    scopus 로고
    • Health Canada's progressive licensing framework
    • Yeates, N., Lee, D.K. & Maher, M. Health Canada's progressive licensing framework. CMAJ 176, 1845-1847 (2007).
    • (2007) CMAJ , vol.176 , pp. 1845-1847
    • Yeates, N.1    Lee, D.K.2    Maher, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.